Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Health Information Technology and Healthcare Information System01:30

Health Information Technology and Healthcare Information System

852
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
852
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

579
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
579
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

3.3K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.3K
Compensation Mechanisms01:28

Compensation Mechanisms

358
The human body employs intricate mechanisms to counteract changes in blood pH, preventing conditions like acidosis (pH < 7.35) and alkalosis (pH > 7.45). These compensatory responses aim to restore normal arterial blood pH by engaging respiratory or renal systems, depending on the source of the imbalance.
Respiratory Compensation
This mechanism addresses metabolic-induced pH imbalances by adjusting breathing rates. Respiratory compensation begins within minutes of detecting a pH...
358
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

2.0K
A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
2.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

When Do Value-Based Contracts Add Value? Insights From Probabilistic Simulations.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2025
Same author

Clinical development success rates for durable cell and gene therapies.

Nature reviews. Drug discovery·2025
Same author

Managing the challenges of paying for gene therapy: strategies for market action and policy reform in the United States.

Journal of comparative effectiveness research·2024
Same author

Creating win-win-win situations with managed entry agreements? Prioritizing gene and cell therapies within the window of opportunity.

Drug discovery today·2024
Same author

Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries.

Expert review of pharmacoeconomics & outcomes research·2023
Same author

Medicaid best price reforms to enable innovative payment models for cell and gene therapies.

Expert review of pharmacoeconomics & outcomes research·2022
Same journal

The economic burden of MASH: comparison of healthcare resource utilization and costs in patients with probable MASH, without MASH, and with diagnosed MASH.

Expert review of pharmacoeconomics & outcomes research·2026
Same journal

Comparative landscape of artificial intelligence-assisted systematic literature reviews.

Expert review of pharmacoeconomics & outcomes research·2026
Same journal

Single versus multiple inhaler triple therapy in COPD using data from the pragmatic INTREPID trial: cost-effectiveness analysis from the Chilean public healthcare system perspective.

Expert review of pharmacoeconomics & outcomes research·2026
Same journal

Real-world direct medical costs and resource utilization of immune checkpoint inhibitors in advanced NSCLC with COPD: a multicenter cost-consequence analysis from Iraq.

Expert review of pharmacoeconomics & outcomes research·2026
Same journal

TENS in chronic pain management: a 11-year nationwide analysis using the French National Health Data System.

Expert review of pharmacoeconomics & outcomes research·2026
Same journal

Economic burden of breast cancer in Cyprus from a societal perspective.

Expert review of pharmacoeconomics & outcomes research·2026
查看所有相关文章

相关实验视频

Updated: Jul 12, 2025

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

3.8K

支付人和开发人员对替代支付模式的看法

Renita Moradian1, Tsega Meshesha1, Mark Trusheim1

  • 1New Drug Development Paradigms (NEWDIGS) Initiative, Center for Biomedical System Design, Tufts Medical Center Institute for Clinical Research and Health Policy Studies, Boston, MA, USA.

Expert review of pharmacoeconomics & outcomes research
|October 26, 2023
PubMed
概括
此摘要是机器生成的。

大多数美国细胞和基因疗法 (CGT) 开发商和支付人正在使用或计划使用替代支付模式. 关键的动机包括管理成本和改善患者接入,尽管存在管理和绩效测量方面的挑战.

关键词:
付款人 付款人 付款人替代支付模式 替代支付模式细胞治疗疗法细胞治疗疗法开发人员是开发人员.基因治疗的基因疗法制造商是制造商的制造商,制造商是制造商的制造商.基于结果的合同是基于结果的合同.基于价值的支付是基于价值的支付.

更多相关视频

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

23.7K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.3K

相关实验视频

Last Updated: Jul 12, 2025

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
06:16

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

3.8K
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

23.7K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.3K

科学领域:

  • 卫生经济学与研究成果研究成果
  • 制药政策和管理 制药政策和管理
  • 生物技术和治疗学

背景情况:

  • 细胞和基因疗法 (CGT) 在美国市场提出了独特的报销挑战.
  • 与CGT相关的高成本和不确定性需要创新的支付解决方案.
  • 了解开发商和付款人的观点对于成功的退款策略至关重要.

研究的目的:

  • 调查美国CGT替代支付模式 (APM) 的采用和动机.
  • 确定在CGT补偿中实施APM的感知障碍和促进者.
  • 探索现实世界的证据在裁决APM合同中的作用.

主要方法:

  • 进行了文献搜索,以告知关于CGT补偿的调查发展.
  • 在2022年6月至8月期间,向美国CGT开发商 (n=100) 和付款人 (n=195) 分发了一项在线调查.
  • 对调查答案的分析,以确定APM实施的趋势,动机和障碍.

主要成果:

  • 大多数开发者 (81%) 和支付者 (84%) 已经实施或计划实施APM.
  • 付款人利用APM来缓解业绩和精算不确定性,而开发者则旨在简化患者的访问和预算影响.
  • 常见的障碍包括行政负担,定义绩效指标和患者流动性;注意到愿意使用现实世界的证据.

结论:

  • 早期讨论和对动机的相互理解对于创建有效的CGT合同至关重要.
  • APM正在成为解决CGT补偿障碍的关键策略.
  • 需要进一步的研究,考虑到研究的参与者限制,以完善CGT的APM框架.